According to initial results of a double-blind.

‘We initiated the International Breast Cancer Intervention Research II Avoidance trial to investigate whether anastrozole may be used effectively to prevent breast cancers,’ stated Jack Cuzick, Ph.D., chairman of the IBIS-II Steering Committee. ‘Our initial results display that for postmenopausal females who don’t have breast malignancy, but are at high risk for developing the condition, anastrozole reduced breast tumor incidence by 53 % with very few side effects. ‘Two additional antihormone therapies, raloxifene and tamoxifen, are used by some women to prevent breast cancer, but these drugs are not as effective and can have adverse side effects, which limit their use,’ explained Cuzick, who is head of the Cancers Research U also.K.In 2008, CSI completed the ORBIT I coronary trial, the first in-individual feasibility study, which enrolled 50 patients in India. These results met the company’s safety and efficacy endpoints and were among the info the FDA regarded as in granting the ORBIT II IDE approval. Dr. Chambers stated, Coronary arterial disease is the most common form of center disease in the United States, affecting a lot more than 16 million people.